Current Price
Target Price
None
e.g. Promoter holding
Loading chart...
Analyst consensus EPS and Revenue forecasts.
Earnings estimates are not available for this company.
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | RB. Riley | RILYZ | $536.78M | — | — | — | — | — | — |
| 2. | APACER BARI... | AAAP | — | — | — | — | — | — | — |
| 3. | AATEST | ATEST | — | — | — | — | — | — | — |
| 4. | AATESTG | ATEST-G | — | — | — | — | — | — | — |
| 5. | AATEST.H | ATEST-H | — | — | — | — | — | — | — |
Consolidated Figures in Millions / View Standalone.
| Quarter (M) | Dec 15 | Mar 16 | Jun 16 | Sep 16 | Dec 16 | Mar 17 | Jun 17 | Sep 17 |
|---|---|---|---|---|---|---|---|---|
Revenue | 18.07 | 16.9 | 18.73 | 17.88 | 21.67 | 19.11 | 22.14 | 23.33 |
COGS | 4.01 | 3.65 | 4.08 | 4.65 | 5.61 | 4.9 | 5.46 | 6.55 |
Gross Profit | 13.74 | 12.9 | 14.27 | 13.23 | 16.06 | 14.21 | 16.3 | 16.77 |
Gross Profit % | 76.04% | 76.33% | 76.19% | 74% | 74.1% | 74.37% | 73.64% | 71.9% |
| 18.24 | 19.27 | 18.8 | 22.22 | 22.9 | 22.04 | 23.94 | 33.98 | |
EBIT | -4.5 | -6.37 | -4.53 | -8.99 | -6.84 | -7.83 | -7.64 | -17.2 |
OPM % | -24.87% | -37.66% | -24.16% | -50.26% | -31.55% | -40.99% | -34.51% | -73.73% |
Non-Operating Income | -0.52 | -0.51 | -0.49 | -0.5 | -0.51 | -0.5 | -0.4 | -0.92 |
PBT | -5.01 | -6.87 | -5.02 | -9.48 | -7.35 | -8.34 | -8.04 | -18.12 |
Income Tax | 0 | 0 | 0 | 0.03 | -0.03 | 0 | 0 | -14.88 |
Tax Rate % | - | - | 0% | -0.36% | 0.38% | -0.04% | -0.04% | 82.12% |
Net Income | -5.01 | -6.87 | -5.02 | -9.52 | -7.32 | -8.34 | -8.04 | -3.24 |
NPM % | -27.74% | -40.66% | -26.81% | -53.24% | -33.77% | -43.64% | -36.33% | -13.89% |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 |
|---|---|---|---|---|---|
Revenue | 17.56 | 32.55 | 48.82 | 61.57 | 75.18 |
COGS | 4.35 | 7.35 | 10.14 | 13.05 | 18.72 |
Gross Profit | 13.21 | 25.2 | 38.68 | 48.52 | 58.55 |
Gross Profit % | 75.21% | 77.42% | 79.24% | 78.8% | 77.88% |
| 37.51 | 42.23 | 0 | 63.37 | 83.18 | |
EBIT | 0 | 0 | -5.1 | -15.86 | -26.71 |
OPM % | - | - | -10.45% | -25.75% | -35.53% |
Non-Operating Income | 0 | 0 | -1.83 | -2.44 | -2.01 |
PBT | 0 | 0 | -6.93 | -18.3 | -28.72 |
Income Tax | 0 | 0 | 0 | 0 | 0.01 |
Tax Rate % | - | - | 0% | 0% | -0.02% |
Net Income | 0 | 0 | -6.93 | -18.3 | -28.73 |
NPM % | - | - | -14.19% | -29.72% | -38.21% |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 |
|---|---|---|---|---|---|
| 6.68 | 7.71 | 3.48 | 28.55 | 21.42 | |
| 6.63 | 0 | 38.21 | 38.21 | 10.85 | |
| 1.22 | 1.35 | 1.73 | 4.13 | 6.49 | |
| 2.02 | 2.69 | 12.07 | 16.27 | 22.64 | |
| 3.99 | 6.13 | -36.26 | 0.21 | 10.7 | |
Total Assets | 20.55 | 17.88 | 19.24 | 87.36 | 72.09 |
| 0 | 0 | 0 | 0.02 | 0.02 | |
| 9.65 | 0 | -100.36 | 57.58 | 35.43 | |
| 7.38 | 15 | 38.24 | 38.24 | 29 | |
| 3.49 | 5.51 | 7.79 | 9.2 | 15.8 | |
| 0.03 | 0.04 | -17.99 | -17.67 | -8.16 | |
Total Liabilities | 20.55 | 20.55 | -72.32 | 87.36 | 72.09 |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 |
|---|---|---|---|---|---|
| 0 | 0 | -8.78 | -14.16 | -20.07 | |
| 2.08 | 6.04 | -1 | -42.05 | 12.27 | |
| 17.36 | 8.2 | 5.55 | 81.28 | 0.78 | |
Net CFNet Cash Flow | 19.44 | 14.24 | -4.22 | 25.06 | -7.13 |
FCFFree Cash Flow | 0 | 0 | -9.78 | -17.56 | -24.06 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 |
|---|---|---|---|---|---|
| - | - | - | 85.6% | -61.8% | |
| 0.76 | - | -0.29 | 0.51 | 0.56 | |
| - | - | 2.00 | 9.02 | 2.20 | |
| - | 1.69 | 2.63 | 1.16 | 0.94 | |
Cash Conversion | - | - | 1.27 | 0.77 | 0.70 |
Payout Ratio | - | - | - | - | - |
| - | 85.3% | 50.0% | 26.1% | 22.1% | |
| - | - | - | - | - | |
| - | - | - | - | - | |
| 1.00 | 2.00 | 3.00 | 4.00 | 4.00 | |
| - | -2.13 | -2.07 | -2.67 | 21.56 | |
| 80.00 | 100.00 | 100.00 | 53.33 | 53.33 | |
| - | - | -0.1% | -0.3% | -0.4% |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Who owns Entellus Medical Inc, from SEC filings
Who owns the company, quarter by quarter
Calendar quarters (13F report dates). Dec 2019 can still change as late 13F amendments arrive.
| Shares held | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | QoQ |
|---|---|---|---|---|---|---|---|---|---|
| 32.5M | 32.5M | 32.4M | 32.4M | 26.2M | 26.2M | 26.1M | 26.0M | -132.6K | |
ForeignForeign institutions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
USUS institutions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Govt.Government & pensions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of institutional holders | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Insiders = officers, directors and 10% owners (Forms 3/4/5). Foreign vs US = the 13F manager's registered address. Government = sovereign funds, central banks and public pensions. Public includes retail investors and funds below the $100M 13F threshold. Named holders are the largest 13F filers each quarter; shares outstanding come from the 10-K / 10-Q cover page.
| Settlement date | Short shares | Change | Days to cover | Relative size |
|---|---|---|---|---|
| 30 Oct 2026 | 9,050 | +141.7% | 1.04 | |
| 15 Oct 2026 | 3,744 | -45.7% | 1.00 | |
| 30 Sep 2026 | 6,891 | +4.9% | 2.21 | |
| 15 Sep 2026 | 6,569 | +29.7% | 2.94 | |
| 31 Aug 2026 | 5,066 | -12.4% | 1.86 | |
| 14 Aug 2026 | 5,784 | +610.6% | 1.00 | |
| 31 Jul 2026 | 814 | +55.3% | 1.00 | |
| 15 Jul 2026 | 524 | -49.1% | 1.00 | |
| 30 Jun 2026 | 1,030 | 1.00 | ||
| 28 Feb 2018 | 266,838 | -7.1% | 2.67 | |
| 15 Feb 2018 | 287,179 | +43.3% | 1.85 | |
| 31 Jan 2018 | 200,378 | -24.5% | 1.05 | |
| 12 Jan 2018 | 265,512 | -43.7% | 1.11 |
FINRA consolidated short interest, reported twice a month for every US listing.
Entellus Medical Inc's SEC filings and earnings call transcripts
What recent news says about Entellus Medical Inc, scored for sentiment.